Staar Surgical Company (STAA) 17.50 $STAA
STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast
PR Newswire - Thu Apr 17, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Ventura County Eye Surgeon Helps Persuade FDA Panel to Support Approval of Long-Awaited Lens Implant
Marketwire - Tue Mar 25, 10:05AM CDT
Ophthalmic surgeon and researcher Dr. Paul Dougherty presented evidence and opinion at the U.S. Food and Drug Administration (FDA) Medical Devices Advisory Committee hearing May 14th that helped persuade the committee to vote in favor of STAAR Surgical's Visian(R) Toric Implantable Collamer(R) Lens (TICL(TM)) -- the first-of-its-kind in the U.S. lens implant designed to treat both nearsightedness and astigmatism in a single procedure.
4 Unusual-Volume Stocks in Breakout Territory
at The Street - Tue Mar 25, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Nasdaq stocks posting largest percentage increases
AP - Mon Mar 24, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Upgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Mon Mar 24, 7:04AM CDT
STAAR Surgical (NASDAQ:STAA) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $16.61 on volume of 334,000 shares, above average daily volume of 296,000. STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
STAAR Surgical Company (STAA) Soars: Stock Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:39AM CDT
STAAR Surgical Company was a big mover last session, as its shares rose over 15% on the day.
Why STAAR Surgical Company Shares Are Seeing Big Gains
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 17, 1:03PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of STAAR Surgical , a developer of...
FDA Advisory Panel Votes in Favor of STAAR Surgical's Visian® Toric Implantable Collamer® Lens, TICL(TM)
PR Newswire - Mon Mar 17, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
IPOs and Transactions: February 24 - 28
PR Newswire - Tue Mar 04, 10:35AM CST
There were 45 transactions filed with the SEC last week.
Visian® ICL(TM) with CentraFLOW® Approved to Market in Japan
PR Newswire - Mon Mar 03, 8:14AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry of Health, Labor and Welfare. With this approval, the range of treatment has been expanded for Visian ICL product offering to include not only the CentraFLOW technology, but also expands the treatment of myopic down to -3.0 diopters as compared to the current range which starts at -5.0 diopters.
STAAR Surgical Reports 15% Fourth Quarter Revenue Growth and 13% Full Year 2013
PR Newswire - Wed Feb 26, 3:01PM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported revenue for the fourth quarter ended January 3, 2014 of $18.9 million, a 15% increase over $16.5 million reported for the fourth quarter of 2012. The effect of foreign currency exchange reduced sales by $1.1 million during the quarter. On a constant currency basis, revenues grew 22% during the fourth quarter of 2013 compared to the fourth quarter of 2012. The results included record quarterly sales of $11.5 million of the Company's Visian® ICL product portfolio and $6.6 million of its IOL products. Low margin Other Product sales were $812,000, a 12% decrease over the prior year and a 3% decrease in constant currency.
Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/qppn9j/contact_lens) has announced the addition of the "Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019. The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Contact Lens Market, by Characteristics Chapter 5 Contact Lens Market, by Design Chapter 6 Contact Lens Market, by Usage Chapter 7 Contact Lens Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/qp...ntact_lens About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
STAAR Surgical To Present At The 34th Annual Cowen Health Care Conference
PR Newswire - Mon Feb 24, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET.
STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast
PR Newswire - Fri Feb 14, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close.
STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast
PR Newswire - Thu Apr 17, 6:00AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close.
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Ventura County Eye Surgeon Helps Persuade FDA Panel to Support Approval of Long-Awaited Lens Implant
Marketwire - Tue Mar 25, 10:05AM CDT
Ophthalmic surgeon and researcher Dr. Paul Dougherty presented evidence and opinion at the U.S. Food and Drug Administration (FDA) Medical Devices Advisory Committee hearing May 14th that helped persuade the committee to vote in favor of STAAR Surgical's Visian(R) Toric Implantable Collamer(R) Lens (TICL(TM)) -- the first-of-its-kind in the U.S. lens implant designed to treat both nearsightedness and astigmatism in a single procedure.
4 Unusual-Volume Stocks in Breakout Territory
at The Street - Tue Mar 25, 5:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
Nasdaq stocks posting largest percentage increases
AP - Mon Mar 24, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Upgrade Alert for STAAR Surgical (STAA)
Comtex SmarTrend(R) - Mon Mar 24, 7:04AM CDT
STAAR Surgical (NASDAQ:STAA) was upgraded from Market Perform to Outperform at William Blair today. The stock closed yesterday at $16.61 on volume of 334,000 shares, above average daily volume of 296,000. STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
STAAR Surgical Company (STAA) Soars: Stock Up 15.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:39AM CDT
STAAR Surgical Company was a big mover last session, as its shares rose over 15% on the day.
Why STAAR Surgical Company Shares Are Seeing Big Gains
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 17, 1:03PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of STAAR Surgical , a developer of...
FDA Advisory Panel Votes in Favor of STAAR Surgical's Visian® Toric Implantable Collamer® Lens, TICL(TM)
PR Newswire - Mon Mar 17, 5:01AM CDT
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the eye and makes recommendations to the Commissioner of Food and Drugs.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
IPOs and Transactions: February 24 - 28
PR Newswire - Tue Mar 04, 10:35AM CST
There were 45 transactions filed with the SEC last week.
Visian® ICL(TM) with CentraFLOW® Approved to Market in Japan
PR Newswire - Mon Mar 03, 8:14AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Visian Implantable Collamer Lens with CentraFLOW technology, which is driven by the KS-AquaPORT, has been approved by the Japanese Ministry of Health, Labor and Welfare. With this approval, the range of treatment has been expanded for Visian ICL product offering to include not only the CentraFLOW technology, but also expands the treatment of myopic down to -3.0 diopters as compared to the current range which starts at -5.0 diopters.
STAAR Surgical Reports 15% Fourth Quarter Revenue Growth and 13% Full Year 2013
PR Newswire - Wed Feb 26, 3:01PM CST
STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported revenue for the fourth quarter ended January 3, 2014 of $18.9 million, a 15% increase over $16.5 million reported for the fourth quarter of 2012. The effect of foreign currency exchange reduced sales by $1.1 million during the quarter. On a constant currency basis, revenues grew 22% during the fourth quarter of 2013 compared to the fourth quarter of 2012. The results included record quarterly sales of $11.5 million of the Company's Visian® ICL product portfolio and $6.6 million of its IOL products. Low margin Other Product sales were $812,000, a 12% decrease over the prior year and a 3% decrease in constant currency.
Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Feb 25, 5:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/qppn9j/contact_lens) has announced the addition of the "Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019. The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Contact Lens Market, by Characteristics Chapter 5 Contact Lens Market, by Design Chapter 6 Contact Lens Market, by Usage Chapter 7 Contact Lens Market, by Geography Chapter 8 Recommendations Chapter 9 Company Profiles List of Figures List of Tables Companies Mentioned - Abbott Medical Optics, Inc. - Alcon Laboratories, Inc. - Bausch & Lomb Incorporated - Carl Zeiss Meditec AG - CooperVision - Essilor International - Hoya Corporation - Johnson & Johnson - STAAR Surgical Company - SynergEyes, Inc. For more information visit http://www.researchandmarkets.com/research/qp...ntact_lens About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
STAAR Surgical To Present At The 34th Annual Cowen Health Care Conference
PR Newswire - Mon Feb 24, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in the 34th Annual Cowen Health Care Conference at the Boston Marriott Copley Place Hotel on Monday, March 3 at 4:50 p.m. ET.
STAAR Surgical Announces Fourth Quarter 2013 Results Release Date, Conference Call And Webcast
PR Newswire - Fri Feb 14, 5:30AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release its financial results for the fourth quarter ended January 3, 2014 on Wednesday, February 26, 2014 after the market close.
